Drug details

Hymovis (high molecular weight viscoelastic hyaluronan)

type of Rheumatologics, Other, Intra-Articular Agents

Hymovis (high molecular weight viscoelastic hyaluronan) is a natural hyaluronan similar to the hyaluronan found in the synovial fluid present in the human joint indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen).

This drug may have the following side effects:

• joint pain,
• joint stiffness,
• joint swelling, and
• injection site reactions (pain, discomfort, redness, swelling, itching).

The following drugs are related to Hymovis, either as a replacement or used together:

• Qutenza (capsaicin 8% patch)
• Celebrex (celecoxib)
• Voltaren (diclofenac sodium)
• Voltaren XR (diclofenac sodium extended-release tablets)
• Voltaren Gel (diclofenac sodium gel)
• Duragesic (fentanyl transdermal)
• Euflexxa (sodium hyaluronate intra-articular injection, 1%)
• Feldene (piroxicam)
• Fentanyl Buccal (fentanyl tablets)
• Hyalgan (hyaluronate)
• Orthovisc (hyaluronan)
• Motrin (ibuprofen)
• Mobic (meloxicam)
• Naprosyn, Anaprox, Anaprox DS (naproxen)
• Oxycontin (oxycodone hcl)
• Roxicodone (oxycodone hydrochloride)
• Supartz FX (sodium hyaluronate solution)
• Ultram (tramadol hcl)